Editorial: Antibody Therapeutics for the Treatment of Filoviral Infection

• Charles D. Murin,
• Bronwyn M. Gunn,
• Paul W. H. I. Parren,
• Paul W. H. I. Parren,
• Gary P. Kobinger

Affiliations

Charles D. Murin

Scripps Research, Department of Integrative Structural and Computational Biology, La Jolla, CA, United States

Bronwyn M. Gunn

Paul G. Allen School of Global Health, Washington State University, Pullman, WA, United States

Paul W. H. I. Parren

Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands

Paul W. H. I. Parren

Lava Therapeutics, Utrecht, Netherlands

Gary P. Kobinger

Galveston National Lab, Galveston, TX, United States